臨床試驗

NRX-101 Expanded Access

NCT：NCT05779267 · AVAILABLE

NCT IDNCT05779267

狀態AVAILABLE

SponsorNeuroRx, Inc. (INDUSTRY)

First posted2023-03-22

Last updated2026-09-17

簡要摘要

The purpose of this Expanded Access Treatment Protocol is to make NRX-101 available to patients who have treatment-resistant depression and who are unable to participate in, or do not have access to, the ongoing NRX-101 clinical trial. The objective of the program is to provide treatment access while monitoring safety in the context of NRX-101 administration paired with theta burst transcranial magnetic stimulation..

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。